{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:17:18Z","timestamp":1790255838778,"version":"4.1.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Recent advances in the understanding of the pathophysiological processes associated with traumatic haemorrhage and trauma-induced coagulopathy (TIC) have resulted in improved outcomes for seriously injured trauma patients. However, a significant number of trauma patients still die from haemorrhage. This article reviews the role of fibrinogen in normal haemostasis, the effect of trauma and TIC on fibrinogen levels and current evidence for fibrinogen replacement in the management of traumatic haemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Fibrinogen is usually the first factor to reach critically low levels in traumatic haemorrhage and hypofibrinogenaemia after severe trauma is associated with increased risk of massive transfusion and death. It is postulated that the early replacement of fibrinogen in severely injured trauma patients can improve outcomes. There is, however, a paucity of evidence to support this, and in addition, there is little evidence to support or refute the effects of cryoprecipitate or fibrinogen concentrate for fibrinogen replacement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The important role fibrinogen plays in haemostasis and effective clot formation is clear. A number of pilot trials have investigated different strategies for fibrinogen replacement in severe trauma. These trials have formed the basis of several large-scale phase III trials, which, cumulatively will provide a firm evidence base to harmonise worldwide clinical management of severely injured trauma patients with major haemorrhage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001027","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T18:21:46Z","timestamp":1623003706000},"page":"514-520","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Fibrinogen in traumatic haemorrhage"],"prefix":"10.1097","volume":"34","author":[{"given":"James","family":"Winearls","sequence":"first","affiliation":[{"name":"Senior Staff Specialist Intensive Care, Gold Coast University Hospital, Gold Coast"},{"name":"Senior Lecturer, School of Medicine, University of Queensland, Brisbane"},{"name":"Senior Lecturer, School of Medical Sciences, Griffith University, Gold Coast"},{"name":"Consultant Intensivist St Andrews War Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Reade","sequence":"additional","affiliation":[{"name":"Professor of Military Medicine and Surgery, Joint Health Command, Australian Defence Force. Faculty of Medicine, University of Queensland"},{"name":"Consultant Intensivist, Royal Brisbane and Women's Hospital, Brisbane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[{"name":"Deputy Director, Transfusion Research Unit, Monash University"},{"name":"Consultant Haematologist, Monash Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Curry","sequence":"additional","affiliation":[{"name":"Consultant Haematologist, Department of Haematology"},{"name":"Head of Department, Oxford Haemophilia & Thrombosis Centre, Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"R1-20250601","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMra1109343","article-title":"Injuries","volume":"368","author":"Norton","year":"2013","journal-title":"N Engl J Med"},{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00268-007-9087-2","article-title":"Epidemiology of urban trauma deaths: a comprehensive reassessment 10\u200ayears later","volume":"31","author":"Cothren","year":"2007","journal-title":"World J Surg"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/SLA.0000000000003657","article-title":"A decade of damage control resuscitation: new transfusion practice, new survivors, new directions","volume":"273","author":"Cole","year":"2019","journal-title":"Ann Surg"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/2013.jamasurg.387","article-title":"The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks","volume":"148","author":"Holcomb","year":"2013","journal-title":"JAMA Surg"},{"key":"R5-20250601","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1213\/ANE.0000000000004478","article-title":"Pathophysiological response to trauma-induced coagulopathy: a comprehensive review","volume":"130","author":"Duque","year":"2020","journal-title":"Anesth Analg"},{"key":"R6-20250601","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCC.0b013e3282f1e78f","article-title":"Acute coagulopathy of trauma: mechanism, identification and effect","volume":"13","author":"Brohi","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"R7-20250601","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/TA.0000000000000729","article-title":"Mechanisms of early trauma-induced coagulopathy: the clot thickens or not?","volume":"79","author":"Dobson","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/ACO.0000000000000295","article-title":"Cause of trauma-induced coagulopathy","volume":"29","author":"Davenport","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"issue":"(Suppl 1)","key":"R9-20250601","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/anae.12914","article-title":"The pathogenesis of traumatic coagulopathy","volume":"70","author":"Cap","year":"2015","journal-title":"Anaesthesia"},{"key":"R10-20250601","first-page":"1211","article-title":"Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis","volume":"64","author":"Brohi","year":"2008","journal-title":"J Trauma"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11739-017-1674-0","article-title":"The current understanding of trauma-induced coagulopathy (TIC): a focused review on pathophysiology","volume":"12","author":"Giordano","year":"2017","journal-title":"Intern Emerg Med"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.TA.0000069184.82147.06","article-title":"Acute traumatic coagulopathy","volume":"54","author":"Brohi","year":"2003","journal-title":"J Trauma"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1097\/CCM.0b013e3182281af5","article-title":"Functional definition and characterization of acute traumatic coagulopathy","volume":"39","author":"Davenport","year":"2011","journal-title":"Crit Care Med"},{"key":"R14-20250601","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R15-20250601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","article-title":"Early coagulopathy predicts mortality in trauma","volume":"55","author":"MacLeod","year":"2003","journal-title":"J Trauma"},{"key":"R16-20250601","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"R17-20250601","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.12431","article-title":"Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy","volume":"54","author":"Levy","year":"2014","journal-title":"Transfusion"},{"key":"R18-20250601","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1213\/ane.0b013e3181966675","article-title":"The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia","volume":"108","author":"Lang","year":"2009","journal-title":"Anesth Analg"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R20-20250601","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1258\/0004563042466884","article-title":"Plasma fibrinogen","volume":"41","author":"Lowe","year":"2004","journal-title":"Ann Clin Biochem"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2174\/1381612043384682","article-title":"The role of the platelet glycoprotein IIb\/IIIa in thrombosis and haemostasis","volume":"10","author":"Fullard","year":"2004","journal-title":"Curr Pharm Design"},{"key":"R22-20250601","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1423-0410.2011.01478.x","article-title":"Fibrinogen concentrates for bleeding trauma patients: what is the evidence?","volume":"101","author":"Meyer","year":"2011","journal-title":"Vox Sang"},{"key":"R23-20250601","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc13798","article-title":"Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study","volume":"18","author":"Hagemo","year":"2014","journal-title":"Crit Care"},{"key":"R24-20250601","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.injury.2010.11.003","article-title":"Early coagulopathy in trauma patients: an on-scene and hospital admission study","volume":"43","author":"Floccard","year":"2012","journal-title":"Injury"},{"key":"R25-20250601","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc10539","article-title":"FIBTEM provides early prediction of massive transfusion in trauma","volume":"15","author":"Schochl","year":"2011","journal-title":"Crit Care"},{"key":"R26-20250601","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jamcollsurg.2012.10.017","article-title":"Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion","volume":"216","author":"Inaba","year":"2013","journal-title":"J Am Coll Surg"},{"key":"R27-20250601","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1538-7836.2012.04752.x","article-title":"Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes","volume":"10","author":"Rourke","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R28-20250601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/bjh.14804","article-title":"Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion: a bi-national cohort study","volume":"179","author":"McQuilten","year":"2017","journal-title":"Br J Haematol"},{"key":"R29-20250601","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.injury.2016.11.021","article-title":"Fibrinogen is an independent predictor of mortality in major trauma patients: a five-year statewide cohort study","volume":"48","author":"McQuilten","year":"2017","journal-title":"Injury"},{"key":"R30-20250601","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.injury.2012.08.047","article-title":"The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma","volume":"44","author":"Innerhofer","year":"2013","journal-title":"Injury"},{"key":"R31-20250601","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jamasurg.2013.764","article-title":"Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study","volume":"148","author":"Morrison","year":"2013","journal-title":"JAMA Surg"},{"key":"R32-20250601","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care"},{"key":"R33-20250601","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"R34-20250601","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"R35-20250601","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1538-7836.2003.0543b.x","article-title":"High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly","volume":"1","author":"van Hylckama Vlieg","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R36-20250601","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/SHK.0000000000000067","article-title":"Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis","volume":"41","author":"Harr","year":"2014","journal-title":"Shock"},{"key":"R37-20250601","first-page":"1231","article-title":"Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: a new paradigm for posttraumatic venous thromboembolism?","volume":"74","author":"Brakenridge","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R38-20250601","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.2004.04868.x","article-title":"Efficacy of standard dose and 30\u200aml\/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients","volume":"125","author":"Chowdary","year":"2004","journal-title":"Br J Haematol"},{"key":"R39-20250601","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00134-014-3584-1","article-title":"Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage","volume":"41","author":"Khan","year":"2015","journal-title":"Intensive Care Med"},{"key":"R40-20250601","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/cc10488","article-title":"Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review","volume":"15","author":"Kozek-Langenecker","year":"2011","journal-title":"Crit Care"},{"key":"R41-20250601","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R42-20250601","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bjs.10052","article-title":"Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice","volume":"103","author":"Stanworth","year":"2016","journal-title":"Br J Surg"},{"key":"R43-20250601","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/trf.13098","article-title":"Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial","volume":"55","author":"Novak","year":"2015","journal-title":"Transfusion"},{"key":"R44-20250601","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/AJCPH16YXJEFSHEO","article-title":"Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol","volume":"136","author":"Chambers","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"(1 Suppl 1)","key":"R45-20250601","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/TA.0b013e31828fa3ed","article-title":"Cryoprecipitate use in the PROMMTT study","volume":"75","author":"Holcomb","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R46-20250601","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/bja\/aes227","article-title":"Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences","volume":"109","author":"Ranucci","year":"2012","journal-title":"Br J Anaesth"},{"key":"R47-20250601","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/bja\/aeu158","article-title":"Cryoprecipitate therapy","volume":"113","author":"Nascimento","year":"2014","journal-title":"Br J Anaesth"},{"key":"R48-20250601","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/voxs.12376","article-title":"Do we need cryoprecipitate in the era of fibrinogen concentrate and other specific factor replacement options?","volume":"13","author":"Wong","year":"2018","journal-title":"ISBT Sci Series"},{"key":"R49-20250601","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17474086.2018.1458610","article-title":"Do we still need cryoprecipitate? Cryoprecipitate and fibrinogen concentrate as treatments for major hemorrhage: how do they compare?","volume":"11","author":"Novak","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"R50-20250601","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.2010.08208.x","article-title":"A critical evaluation of cryoprecipitate for replacement of fibrinogen","volume":"149","author":"Sorensen","year":"2010","journal-title":"Br J Haematol"},{"key":"R51-20250601","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-3148.2012.01158.x","article-title":"Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England","volume":"22","author":"Tinegate","year":"2012","journal-title":"Transfus Med"},{"key":"R52-20250601","first-page":"CD008864","article-title":"Fibrinogen concentrate in bleeding patients","volume":"8","author":"Wikkelso","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R53-20250601","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jss.2014.01.055","article-title":"In vitro efficacy of RiaSTAP after rapid reconstitution","volume":"190","author":"Karri","year":"2014","journal-title":"J Surg Res"},{"key":"R54-20250601","first-page":"171","article-title":"Targeted fibrinogen concentrate use in severe traumatic haemorrhage","volume":"21","author":"Seebold","year":"2019","journal-title":"Crit Care Resusc"},{"key":"R55-20250601","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/trf.15917","article-title":"The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients","volume":"60","author":"Wirtz","year":"2020","journal-title":"Transfusion"},{"key":"R56-20250601","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/vox.12417","article-title":"Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients: an economic evaluation","volume":"111","author":"Okerberg","year":"2016","journal-title":"Vox Sang"},{"key":"R57-20250601","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042185","article-title":"Fibrinogen replacement therapy for traumatic coagulopathy: does the fibrinogen source matter?","volume":"22","author":"Morrow","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R58-20250601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"R59-20250601","doi-asserted-by":"crossref","first-page":"e000037","DOI":"10.1136\/tsaco-2016-000037","article-title":"Preemptive administration of fibrinogen concentrate contributes to improved prognosis in patients with severe trauma","volume":"1","author":"Yamamoto","year":"2016","journal-title":"Trauma Surg Acute Care Open"},{"key":"R60-20250601","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol"},{"key":"R61-20250601","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy","volume":"15","author":"Schochl","year":"2011","journal-title":"Crit Care"},{"key":"R62-20250601","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bja\/aen270","article-title":"Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations","volume":"101","author":"Fenger-Eriksen","year":"2008","journal-title":"Br J Anaesth"},{"key":"R63-20250601","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/aas.12734","article-title":"Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review","volume":"60","author":"Jensen","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"R64-20250601","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/TA.0000000000002920","article-title":"Use of fibrinogen concentrate for trauma-related bleeding: a systematic-review and meta-analysis","volume":"89","author":"Stabler","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"R65-20250601","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/bja\/aew343","article-title":"Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial","volume":"117","author":"Nascimento","year":"2016","journal-title":"Br J Anaesth"},{"key":"R66-20250601","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-018-2086-x","article-title":"Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multicentre, randomised, double blind, placebo-controlled pilot trial","volume":"22","author":"Curry","year":"2018","journal-title":"Crit Care"},{"key":"R67-20250601","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/bja\/aev134","article-title":"Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial","volume":"115","author":"Curry","year":"2015","journal-title":"Br J Anaesth"},{"key":"R68-20250601","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bja.2018.10.055","article-title":"Coagulopathy, cryoprecipitate and CRYOSTAT-2: realising the potential of a nationwide trauma system for a national clinical trial","volume":"122","author":"Marsden","year":"2019","journal-title":"Br J Anaesth"},{"issue":"(Suppl 1)","key":"R69-20250601","article-title":"Fiirst-2: prospective, randomized study comparing administration of clotting factor concentrates with standard massive hemorrhage protocol in severely bleeding trauma patients","volume":"136","author":"Da Luz","year":"2020","journal-title":"Blood"},{"key":"R70-20250601","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13063-016-1439-5","article-title":"Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial","volume":"17","author":"Steinmetz","year":"2016","journal-title":"Trials"},{"key":"R71-20250601","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ACO.0000000000001028","article-title":"Prehospital administration of blood and plasma products","volume":"34","author":"Roehl","year":"2021","journal-title":"Curr Opin Anesthesiol"},{"key":"R72-20250601","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/EJA.0000000000001366","article-title":"Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): a multicentre, double-blind, placebo-controlled, randomised pilot study","volume":"38","author":"Ziegler","year":"2020","journal-title":"Eur J Anaesthesiol"},{"key":"R73-20250601","first-page":"32","article-title":"Fibrinogen Early In Severe Trauma studY (FEISTY): results from an Australian multicentre randomised controlled pilot trial","volume":"23","author":"Winearls","year":"2021","journal-title":"Crit Care Resusc"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:12:14Z","timestamp":1748815934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001027","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]}}}